Functional studies of soluble low‐affinity interleukin‐2 receptors in rheumatoid synovial fluid
- 1 November 1990
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 33 (11) , 1688-1694
- https://doi.org/10.1002/art.1780331112
Abstract
Since abnormal regulation of interleukin‐2 (IL‐2) has been demonstrated in rheumatoid arthritis (RA), the functional role of low‐affinity soluble IL‐2 receptors (sIL‐2R) purified from RA synovial fluids (SF) was studied. Picomolar levels of sIL‐2R were detected in RA SF using an enzyme‐linked immunosorbent assay. Levels were higher in serum and SF from RA patients than in controls (P < 0.001) and higher in RA SF than in paired RA serum (P < 0.01). Soluble IL‐2R from RA SF had estimated molecular weights of 40‐50 kd and 80–100 kd by gel filtration analysis. The 80–100‐kd peak is likely to be a dimer of the 40–50‐kd peak, since a single 45‐kd peak was found after elution from sodium dodecyl sulfate‐polyacrylamide gels. Since inhibitory activity for lymphocyte proliferation was found in the 80–100‐kd range, the sIL‐2R were purified with an anti‐CD25 affinity column and further analyzed. The purified fractions did not interfere with the proliferation of mitogen‐stimulated lymphocytes or with the binding of radiolabeled IL‐2 to CTLL‐2 cells, although direct binding of IL‐2 was demonstrated. The affinity of sIL‐2R from RA SF for binding IL‐2 was in the range of 25 nM, which is similar to the affinity of sIL‐2R purified from a human T cell clone, indicating that both sIL‐2R are low‐affinity receptors for IL‐2. We conclude that the concentration and binding affinity of low‐affinity sIL‐2R purified from RA SF render them unable to interfere with IL‐2‐related activities.This publication has 29 references indexed in Scilit:
- Autoantibodies to cytokines - friends or foes?Immunology Today, 1990
- CD23: a multi-functional receptor/ lymphokine?Immunology Today, 1989
- The bimolecular structure of the interleukin 2 receptorImmunology Today, 1988
- Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis.The Journal of Experimental Medicine, 1988
- Serum levels of interleukin‐2 receptor and activity of rheumatic diseases characterized by immune system activationArthritis & Rheumatism, 1988
- Rheumatoid arthritis: An editorial perspective based on cytokine imbalanceJournal of Autoimmunity, 1988
- Elevated soluble interleukin‐2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritisArthritis & Rheumatism, 1988
- Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid jointClinical Immunology and Immunopathology, 1987
- Inhibitor of interleukin‐2 in rheumatoid synovial fluidArthritis & Rheumatism, 1987